News

Health and Me on MSN4d
FDA Greenlights Nucala as New Treatment for COPD
FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients ...
Wyoming Tribune Eagle5d
FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients ...
MedPage Today5d
FDA Approves Mepolizumab for COPD
Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...
COPD News Today5d
FDA approves Nucala as add-on therapy for certain COPD patients
The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...
Contract Pharma5d
FDA Greenlights GSK’s Nucala for Eosinophilic COPD
The FDA has granted approval to GSK's Nucala as an add-on maintenance treatment for adult patients suffering from inadequately controlled COPD.
MPR5d
FDA Approves Nucala for COPD With an Eosinophilic Phenotype
The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...
BioSpace5d
GSK Wins COPD Expansion for Nucala After FDA Delay
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Managed Healthcare Executive5d
FDA Approves Nucala as Maintenance Therapy for COPD
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
Pharmaceutical Technology on MSN5d
FDA approves GSK’s Nucala to treat COPD
GSK respiratory, immunology and inflammation research and development (R&D) global head and senior vice-president Kaivan ...
Share Prices5d
GSK's Nucala wins FDA approval for COPD with eosinophilic inflammation
(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration has approved its asthma drug Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary ...
BMJ6d
Oxygen therapy and inpatient mortality in COPD exacerbation
However, the new scale requires proof of hypercapnia and clinician approval which may paradoxically result in more patients with COPD initially receiving the default 94%–98% range. An randomised ...